ESTIMATION OF BLOOD-GLUCOSE VARIABILITY IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS

被引:27
|
作者
MOBERG, E
KOLLIND, M
LINS, PE
ADAMSON, U
机构
关键词
METABOLIC CONTROL; SELF-MONITORING OF BLOOD GLUCOSE; UNSTABLE DIABETES;
D O I
10.3109/00365519309092547
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the study described here was to evaluate the standard deviation (SD) as a measure of blood-glucose variability in IDDM patients under 'normal life' conditions. One hundred IDDM patients performed self-monitoring of blood glucose (SMBG) five times every 2 days for 4 weeks. From these records the following measurements were calculated for each patient: the standard deviation of all blood-glucose values (SD(BG)), the M-value, the percentage of values < 3 and > 15 mmol l-1 (PE), and the mean, absolute difference of consecutive blood-glucose values (MAD), a novel measure of blood-glucose variability, also taking into consideration the succession of the values. Before the study the patients as well as their physicians were asked to estimate the blood-glucose stability of the patient, using a five-category scale of statements. The patients recorded an average of 64 (range: 32-70) SMBG values. The SD(BG) was normally distributed with a mean of 3.9 +/- 1.0 mmol l-1. There was a highly significant correlation between the SD(BG) and the other measures of blood-glucose variability (p = 0.0001, r > 0.8). It appeared that the variation of the SMBG values recorded before dinner contributed to the total glucose variability to a great extent. There was a poor agreement between the subjective estimations of the blood-glucose stability made by the patients and the physicians and the objective measures of the blood-glucose variability. It is concluded that the SD provides an accurate and easily available estimate of blood-glucose variability in IDDM patients practising home blood-glucose monitoring.
引用
收藏
页码:507 / 514
页数:8
相关论文
共 50 条
  • [41] CARDIAC AUTONOMIC NEUROPATHY AND BLOOD-PRESSURE VARIABILITY IN INSULIN-DEPENDENT DIABETES-MELLITUS
    COMBE, H
    BAUDUCEAU, B
    CHANUDET, X
    CHAU, NP
    RABASA, R
    MEYER, L
    MAYAUDON, H
    LARROQUE, P
    GAUTIER, D
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1993, 86 (08): : 1149 - 1152
  • [42] IMPORTANCE OF GROWTH-HORMONE FOR BLOOD-GLUCOSE REGULATION FOLLOWING INSULIN-INDUCED NOCTURNAL HYPOGLYCEMIA IN INSULIN-DEPENDENT DIABETES-MELLITUS
    KOLLIND, M
    ADAMSON, U
    LINS, PE
    CURSTEDT, T
    ACTA MEDICA SCANDINAVICA, 1988, 223 (02): : 159 - 164
  • [43] INSULIN RESISTANCE AND INSULIN-DEPENDENT DIABETES-MELLITUS
    PEDERSEN, O
    BECKNIELSEN, H
    DIABETES CARE, 1987, 10 (04) : 516 - 523
  • [44] EATING DISORDERS IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS
    ROSMARK, B
    BERNE, C
    HOLMGREN, S
    LAGO, C
    RENHOLM, G
    SOHLBERG, S
    JOURNAL OF CLINICAL PSYCHIATRY, 1986, 47 (11) : 547 - 550
  • [45] ORAL HEALTH OF PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS
    TENOVUO, J
    ALANEN, P
    LARJAVA, H
    VIIKARI, J
    LEHTONEN, OP
    SCANDINAVIAN JOURNAL OF DENTAL RESEARCH, 1986, 94 (04): : 338 - 346
  • [46] NOCTURNAL HYPOGLYCEMIA IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS
    BENDTSON, I
    DANISH MEDICAL BULLETIN, 1995, 42 (03) : 269 - 284
  • [47] PERIPHERAL NEUROPATHY IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS
    MONGA, TN
    REDMOND, DL
    LAWSON, JS
    BIRD, CE
    DONALD, MW
    LETEMENDIA, FJJ
    SURRIDGE, DHC
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A149 - A149
  • [48] THE EFFECT OF HYPERGLUCAGONEMIA ON BLOOD-GLUCOSE CONCENTRATIONS AND ON INSULIN REQUIREMENTS DURING FASTING IN INSULIN DEPENDENT DIABETES-MELLITUS
    CLARKE, WL
    MELTON, TW
    BRIGHT, GM
    ACTA ENDOCRINOLOGICA, 1983, 102 (04): : 557 - 560
  • [49] AUTOIMMUNITY AND INSULIN-DEPENDENT DIABETES-MELLITUS
    CAMPBELL, IL
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1988, 18 (03): : 392 - 392
  • [50] AUTOIMMUNITY IN INSULIN-DEPENDENT DIABETES-MELLITUS
    BOSI, E
    BOTTAZZO, GF
    CLINICAL IMMUNOTHERAPEUTICS, 1995, 3 (02): : 125 - 135